Noguchi S, Yamasaki R, Nagai-Yoshioka Y, Sato T, Kuroishi K, Gunjigake K
Int J Mol Sci. 2023; 24(19).
PMID: 37834290
PMC: 10573633.
DOI: 10.3390/ijms241914842.
Leite-Silva J, Oliveira-Ribeiro C, Morgado F, Pimentel M, Lyra M, Fagundes A
Microorganisms. 2023; 11(7).
PMID: 37512804
PMC: 10384164.
DOI: 10.3390/microorganisms11071631.
Beetler D, Bruno K, Di Florio D, Douglass E, Shrestha S, Tschope C
Front Cardiovasc Med. 2023; 9:1073814.
PMID: 36741845
PMC: 9889877.
DOI: 10.3389/fcvm.2022.1073814.
Gonzalez L, Rivera K, Andia M, Rodriguez G
Int J Mol Sci. 2023; 24(1).
PMID: 36613465
PMC: 9820551.
DOI: 10.3390/ijms24010017.
Ikutani M, Nakae S
Front Immunol. 2022; 13:939378.
PMID: 35844571
PMC: 9278653.
DOI: 10.3389/fimmu.2022.939378.
The Controversial Role of IL-33 in Lung Cancer.
Yang K, Tian C, Zhang C, Xiang M
Front Immunol. 2022; 13:897356.
PMID: 35634336
PMC: 9134343.
DOI: 10.3389/fimmu.2022.897356.
Inflammatory Mediators in Atherosclerotic Vascular Remodeling.
Evans B, Yerly A, van der Vorst E, Baumgartner I, Bernhard S, Schindewolf M
Front Cardiovasc Med. 2022; 9:868934.
PMID: 35600479
PMC: 9114307.
DOI: 10.3389/fcvm.2022.868934.
Interleukin-33/ Suppression of Tumorigenicity 2 in Renal Fibrosis: Emerging Roles in Prognosis and Treatment.
Tan X, Jing H, Ma Y
Front Physiol. 2022; 12:792897.
PMID: 35046838
PMC: 8761767.
DOI: 10.3389/fphys.2021.792897.
Role of the IL-33/ST2 axis in cardiovascular disease: A systematic review and meta-analysis.
Sun Y, Pavey H, Wilkinson I, Fisk M
PLoS One. 2021; 16(11):e0259026.
PMID: 34723980
PMC: 8559957.
DOI: 10.1371/journal.pone.0259026.
Serum soluble suppression of tumorigenicity 2 as a novel inflammatory marker predicts the severity of acute pancreatitis.
Zhang Y, Cheng B, Wu Z, Cui Z, Song Y, Chen S
World J Gastroenterol. 2021; 27(38):6489-6500.
PMID: 34720537
PMC: 8517782.
DOI: 10.3748/wjg.v27.i38.6489.
Airway Exposure to Polyethyleneimine Nanoparticles Induces Type 2 Immunity by a Mechanism Involving Oxidative Stress and ATP Release.
Srisomboon Y, Ohkura N, Iijima K, Kobayashi T, Maniak P, Kita H
Int J Mol Sci. 2021; 22(16).
PMID: 34445774
PMC: 8396525.
DOI: 10.3390/ijms22169071.
Dual role of interleukin-33 in tumors.
Liu Q, Lu D, Hu J, Liang J, Chen H
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021; 46(2):169-175.
PMID: 33678654
PMC: 10929784.
DOI: 10.11817/j.issn.1672-7347.2021.190678.
Anti-Tumorigenic Activities of IL-33: A Mechanistic Insight.
Andreone S, Gambardella A, Mancini J, Loffredo S, Marcella S, La Sorsa V
Front Immunol. 2020; 11:571593.
PMID: 33329534
PMC: 7734277.
DOI: 10.3389/fimmu.2020.571593.
Early Treatment of Interleukin-33 can Attenuate Lupus Development in Young NZB/W F1 Mice.
Mohd Jaya F, Liu Z, Chan G
Cells. 2020; 9(11).
PMID: 33182616
PMC: 7696801.
DOI: 10.3390/cells9112448.
Epithelial cells expressed IL-33 to promote degranulation of mast cells through inhibition on ST2/PI3K/mTOR-mediated autophagy in allergic rhinitis.
Nian J, Zeng M, Zheng J, Zeng L, Fu Z, Huang Q
Cell Cycle. 2020; 19(10):1132-1142.
PMID: 32298206
PMC: 7217365.
DOI: 10.1080/15384101.2020.1749402.
ST2 and regulatory T cells in the colorectal adenoma/carcinoma microenvironment: implications for diseases progression and prognosis.
Cui G, Yuan A, Li Z, Goll R, Florholmen J
Sci Rep. 2020; 10(1):5892.
PMID: 32246094
PMC: 7125220.
DOI: 10.1038/s41598-020-62502-0.
Possible Roles of IL-33 in the Innate-Adaptive Immune Crosstalk of Psoriasis Pathogenesis.
Cannavo S, Bertino L, Di Salvo E, Papaianni V, Ventura-Spagnolo E, Gangemi S
Mediators Inflamm. 2019; 2019:7158014.
PMID: 31736655
PMC: 6815589.
DOI: 10.1155/2019/7158014.
Interleukin 33/ST2 Axis Components Are Associated to Desmoplasia, a Metastasis-Related Factor in Colorectal Cancer.
Landskron G, De la Fuente Lopez M, Dubois-Camacho K, Diaz-Jimenez D, Orellana-Serradell O, Romero D
Front Immunol. 2019; 10:1394.
PMID: 31281317
PMC: 6598075.
DOI: 10.3389/fimmu.2019.01394.
IL33/ST2 Axis in Diabetic Kidney Disease: A Literature Review.
Tonacci A, Quattrocchi P, Gangemi S
Medicina (Kaunas). 2019; 55(2).
PMID: 30769901
PMC: 6410122.
DOI: 10.3390/medicina55020050.
Elevated Sera sST2 Is Associated With Heart Failure in Men ≤50 Years Old With Myocarditis.
Coronado M, Bruno K, Blauwet L, Tschope C, Cunningham M, Pankuweit S
J Am Heart Assoc. 2019; 8(2):e008968.
PMID: 30638108
PMC: 6497352.
DOI: 10.1161/JAHA.118.008968.